Cite
HARVARD Citation
Weide, R. et al. (n.d.). Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions. Leukemia & lymphoma. 54 (8), pp. 1640-1646. [Online].